Crispr Therapeutics (CRSP) stock valuation

$42.01 Nov 18, 2026 · market cap $3.8B

NEUTRALSep 23, 20267/121 investors
i

Crispr Therapeutics trades at $42. We don't have a valuation for it yet.

NEUTRAL · low confidence · Sep 23, 2026

7 of 121 tracked investors hold it · Q3 2026 13F filings

Estimates from SEC filings and market data; the verdict is AI research. Not investment advice. Get the iPhone app · Get the Android app

5 AI analysts debate CRSPCreate free account →

Full open-source research report for CRSP on DeepValues Research (CC BY 4.0)